None listed
Conditions
Interventions
Experimental group:Take Probiotics with LumosMaxTM
Sponsors
Meimo (Beijing) Technology Co., Ltd.
Eligibility
Sex/Gender
All
Age
25 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Subjects aged 25-40 years, no gender limit; 2. According to the pressure perception scale (CPSS) (tentative) into the group; 3. Subjects at high risk of abnormal glucose metabolism regulation, fasting blood glucose is 6.1-6.9; 4. Subjects with high blood lipid risk; 5. Self-assessment prone to hair loss (As soon as you brush your hair, dry your hair. Pick up a small bundle of hair, about a hundred or so, pull it slightly with your fingers and comb through the small bundle of hair. If there are more than three (not including 3) , is selected.); 6. Self-feeling greasy scalp; 7. Have not yet used drug treatment; 8. Willingness to comply with all research requirements and procedures; 9. Agree to sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Subjects with metabolic syndrome who are medically diagnosed with diabetes and have been treated with drugs. 2. Gastrointestinal symptoms are being treated. 3. Currently suffering from diarrhea. 4. Use analgesics such as aspirin or paracetamol. 5. Use of laxatives or other digestion-promoting substances 2 weeks before the start of the test. 6. Long-term use of probiotic powder for treatment or consumption of yogurt and beverages containing probiotics during the study period. 7. Long-term use of drugs that inhibit or prevent symptoms of upper respiratory tract infections, such as antihistamines, cough suppressants, high-dose vitamin C, etc. 8. Taking drugs that affect the immune response, such as antibiotics, in the past 3 months. 9. Vaccination against upper respiratory tract infection within the past 6 months, or other vaccination within 15 days. 10. Those who are addicted to alcohol or drugs. 11. Pregnant or lactating subjects, or those who plan to become pregnant during the trial period. 12. Those who have participated in other clinical trials in the past 3 months. 13. Some expected blood sugar continued to rise and entered the medical treatment period, and the volunteers automatically dropped out of the group. 14. The researcher believes that the volunteers cannot fully cooperate with the experimental arrangement. 15. Suffering from organic lesions of the scalp.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose;Glycated hemoglobin;Blood insulin;High density lipoprotein;Low-density lipoprotein;Cholesterol;Triglyceride;C-reactive protein;Malondialdehyde;Superoxide dismutase;Immunoglobulin;IFN-?;IL-6;IL-10;IL-31;Vitamin B7; | — |
Secondary
| Measure | Time frame |
|---|---|
| Scalp moisture;Scalp transepidermal water loss;Scalp pH value;Scalp greasy level;Facial skin hydration;Transepidermal water loss from cheeks;Facial pH;Forehead fat index;Saliva cortisol;Urine rountine; | — |
Countries
China
Contacts
Public ContactOuyang Tianxiang
Outcome results
None listed